Literature DB >> 16879012

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.

Chung-Che Jeff Chang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16879012     DOI： 10.5858/2006-130-1123-ACMD

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  2 in total

1.  The JAK2(V617F) tyrosine kinase mutation in blood donors with upper-limit haematocrit levels.

Authors:  Giuseppe Tagariello; Rosanna Di Gaetano; Roberto Sartori; Daniela Zanotto; Donata Belvini; Paolo Radossi; Renzo Risato; Giovanni Roveroni; Roberta Salviato; Cristina Tassinari; Nunzio Toffano
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

2.  Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts.

Authors:  Juan Zhou; Yuanxin Ye; Shugen Zeng; Yi Zhou; Zhigang Mao; Xingbo Song; Binwu Ying; Xiaojun Lu; Hong Jiang; Lanlan Wang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.